Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
ATOMAID 100mg capsules
0404000S0BCAAAH
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 10mg capsules
0404000S0BCAGAA
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 18mg capsules
0404000S0BCAFAC
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 25mg capsules
0404000S0BCAEAD
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 40mg capsules
0404000S0BCADAB
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 60mg capsules
0404000S0BCACAE
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
ATOMAID 80mg capsules
0404000S0BCABAF
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.